Proto Labs (NYSE:PRLB – Get Free Report) issued an update on its fourth quarter earnings guidance on Friday morning. The company provided earnings per share guidance of $0.15-0.18 for the period, compared to the consensus earnings per share estimate of $0.29. The company issued revenue guidance of $115-123 million, compared to the consensus revenue estimate of $120.01 million. Proto Labs also updated its Q4 2024 guidance to 0.280-0.360 EPS.
Proto Labs Stock Performance
PRLB traded down $3.74 during trading on Monday, reaching $34.26. 333,823 shares of the company’s stock were exchanged, compared to its average volume of 191,129. The company’s fifty day moving average price is $28.99 and its 200-day moving average price is $30.44. Proto Labs has a fifty-two week low of $25.75 and a fifty-two week high of $41.87. The firm has a market capitalization of $861.64 million, a PE ratio of 35.83 and a beta of 1.32.
Proto Labs (NYSE:PRLB – Get Free Report) last released its earnings results on Friday, November 1st. The industrial products company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.32 by $0.15. Proto Labs had a net margin of 4.86% and a return on equity of 3.60%. The firm had revenue of $125.60 million during the quarter, compared to analyst estimates of $121.38 million. During the same quarter in the previous year, the business earned $0.31 EPS. The business’s quarterly revenue was down 3.9% compared to the same quarter last year. Research analysts forecast that Proto Labs will post 0.7 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on PRLB
Insider Activity
In other news, CEO Robert Bodor purchased 3,480 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were purchased at an average cost of $28.68 per share, with a total value of $99,806.40. Following the completion of the purchase, the chief executive officer now owns 80,878 shares of the company’s stock, valued at $2,319,581.04. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 1.20% of the company’s stock.
Proto Labs Company Profile
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Further Reading
- Five stocks we like better than Proto Labs
- How to Choose Top Rated Stocks
- Intel: Is Now the Time to Be Brave?Â
- How to Use the MarketBeat Dividend Calculator
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Business Services Stocks Investing
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.